J. Aerts

New Roads Open Up for Implementing Immunotherapy in Mesothelioma

H. Hoogsteden, J. Aerts, R. Hendriks, 2012, Clinical & developmental immunology.

Consolidative dendritic cell-based immunotherapy elicits cytotoxicity against malignant mesothelioma.

H. Hoogsteden, B. Lambrecht, C. Figdor, 2010, American journal of respiratory and critical care medicine.

Extended Tumor Control after Dendritic Cell Vaccination with Low Dose Cyclophosphamide as Adjuvant Treatment in Patients with Malignant Pleural Mesothelioma at a Glance Commentary

H. Hoogsteden, J. Aerts, R. Hendriks, 2022 .

Renal toxicity from pemetrexed and pembrolizumab in the era of combination therapy in patients with metastatic non-squamous cell NSCLC.

J. Vansteenkiste, T. van Gelder, R. Cornelissen, 2020, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Overcoming immune checkpoint blockade resistance in solid tumors with intermittent ITK inhibition

H. V. D. van de Werken, P. Katsikis, Floris Dammeijer, 2023, Scientific reports.

Extended Tumor Control after Dendritic Cell Vaccination with Low-Dose Cyclophosphamide as Adjuvant Treatment in Patients with Malignant Pleural Mesothelioma.

H. Hoogsteden, J. Hegmans, K. Bezemer, 2016, American journal of respiratory and critical care medicine.